previous compound ID: 169 next compound
InChIKey: AQXXZDYPVDOQEE-MXDQRGINSA-N
SMILES: CN1CCCN=C1/C=C/C2=CC=CS2.C1=CC=C2C(=C1)C=C(C(=C2CC3=C(C(=CC4=CC=CC=C43)C(=O)O)O)O)C(=O)O

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"B Kus" "DY Thomas" "SD Macknight" "GW Carlile" "JW Hanrahan" "J Liao" "E Matthes" "R Robert" "D Rotin" "J Goepp"

chemical graph of compound 169





CID is 5281033
synonyms found at PubChem are:
pyrantel pamoate, 22204-24-6, Pyrantel embonate, Antiminth, Combantrin, Embovin, Pyrantel (pamoate), CP-10,423-16, UNII-81BK194Z5M, EINECS 244-837-1, NSC 355080, CHEBI:8655, 81BK194Z5M, NSC355080, (E)-1,4,5,6-Tetrahydro-1-methyl-2-(2-(2-thienyl)vinyl)pyrimidine 4,4'-methylenebis(3-hydroxy-2-naphthoate) (1:1), (E)-1-methyl-2-(2-(thiophen-2-yl)vinyl)-1,4,5,6-tetrahydropyrimidine 4,4'-methylenebis(3-hydroxy-2-naphthoate), 2-Naphthalenecarboxylic acid, 4,4'-methylenebis(3-hydroxy-, compd. with (E)-1,4,5,6-tetrahydro-1-methyl-2-(2-(2-thienyl)ethenyl)pyrimidine (1:1), Sentry hc worm X, 2-Naphthoic acid, 4,4'-methylenebis(3-hydroxy-, compd. with (E)-1,4,5,6-tetrahydro-1-methyl-2-(2-(2-thienyl)vinyl)pyrimidine (1:1), 4,4'-Methylenebis(3-hydroxy-2-naphthoic) acid, compound with (E)-1,4,5,6-tetrahydro-1-methyl-2-(2-(2-thienyl)vinyl)pyrimidine (1:1), Pyrimidine, 1,4,5,6-tetrahydro-1-methyl-2-(2-(2-thienyl)ethenyl)-, (E)-, compd. with 4,4'-methylenebis(3-hydroxy-2-naphthalenecarboxylic acid) (1:1), Sentry hc worm X DS, Vetscription sure shot 2X, Cobantril, Helmintox, Nemocid, Piranver, Helmex, Pyrantel pamoate [USAN:JAN], Early Bird, Antiminth (TN), Pyrantel pamoate [USAN:USP:JAN], 4-[(3-carboxy-2-hydroxynaphthalen-1-yl)methyl]-3-hydroxynaphthalene-2-carboxylic acid;1-methyl-2-[(E)-2-thiophen-2-ylethenyl]-5,6-dihydro-4H-pyrimidine, C23H16O6.C11H14N2S, AC1NQXXE, Spectrum5_001373, Pyrantel pamoate, BioXtra, (3-hydroxy-2-naphthoate), SCHEMBL41025, SPECTRUM1500517, Pyrantel pamoate (JP17/USP), SCHEMBL7793068, CHEMBL1599768, C34H30N2O6S, HMS500M16, Pyrantel Pamoate Sigmaultra,(S), MolPort-003-666-276, HMS1920N06, HMS2090J21, HMS2092E07, Pharmakon1600-01500517, CCG-39242, NSC757303, STL481883, AKOS015908224, CS-3869, NSC-355080, NSC-757303, IDI1_000254, NCGC00094552-01, NCGC00094552-02, NCGC00094552-03, 2-Naphthalenecarboxylic acid, 4,4'-methylenebis(3-hydroxy), compd. with (E)-1,4,5,6-tetrahydro-1-methyl-2-(2-(2-thienyl)ethenyl)pyrimidine (1:1), AC-24204, AK198640, AS-12185, CC-34082, HY-12640, LS-95387, SBI-0051499.P003, AB2000606, CP 10423-16, CP-10423-16, C07389, D00486, 204P246, A816013, SR-05000001708, SR-05000001708-1, Pyrantel pamoate, VETRANAL(TM), analytical standard, (E)-1-methyl-2-(2-(thiophen-2-yl)vinyl)-1,4,5,6, Pyrantel embonate, European Pharmacopoeia (EP) Reference Standard, Pyrantel pamoate, United States Pharmacopeia (USP) Reference Standard, (E)-1,5,6-Tetrahydro-1-methyl-2-[2-(2-thienyl)vinyl]pyrimidine 4,4'-methylenebis[3-hydroxy-2-naphthoate] (1:1), 1,4,5,6-Tetrahydro-1-methyl-2-[(1E)-2-(2-thienyl)ethenyl]pyrimidine 4,4'-Methylenebis[3-hydroxy-2-naphthalenecarboxylate], 1-Methyl-2-(2-[2-thienyl]ethenyl)-1,4,5,6-tetrahydropyrimidine compound with 4,4 inverted exclamation marka-methylenebis(3-hydroxy-2-naphthoic acid), 1-Methyl-2-(2-[2-thienyl]ethenyl)-1,4,5,6-tetrahydropyrimidine compound with 4,4'-methylenebis(3-hydroxy-2-naphthoic acid), 122157-48-6, 2-Naphthalenecarboxylic acid, 4,4'-methylenebis(3-hydroxy-, compd. with 1,4,5,6-tetrahydro-1-methyl-2-((1E)-2-(2-thienyl)ethenyl)pyrimidine (1:1), 2-Naphthalenecarboxylic acid,4'-methylenebis[3-hydroxy-, compd. with (E)-1,4,5,6-tetrahydro-1-methyl-2-[2-(2-thienyl)ethenyl]pyrimidine (1:1), 2-Naphthoic acid,4'-methylenebis[3-hydroxy-, compd. with (E)-1,4,5,6-tetrahydro-1-methyl-2-[2-(2-thienyl)vinyl]pyrimidine (1:1), 4,4'-methanediylbis(3-hydroxynaphthalene-2-carboxylic acid) - 1-methyl-2-[(E)-2-(thiophen-2-yl)ethenyl]-1,4,5,6-tetrahydropyrimidine (1:1), 4,4'-Methylenebis[3-hydroxy-2-naphthalenecarboxylic Acid compound with 1,4,5,6-Tetrahydro-1-methyl-2-[(1E)-2-(2-thienyl)ethenyl]pyrimidine, 4-[(3-carboxy-2-hydroxy-1-naphthalenyl)methyl]-3-hydroxy-2-naphthalenecarboxylic acid; 1-methyl-2-[(E)-2-thiophen-2-ylethenyl]-5,6-dihydro-4H-pyrimidine, 4-[(3-carboxy-2-hydroxy-1-naphthyl)methyl]-3-hydroxy-naphthalene-2-carboxylic acid; 1-methyl-2-[(E)-2-(2-thienyl)vinyl]-5,6-dihydro-4H-pyrimidine, 4-[(3-carboxy-2-hydroxynaphthalen-1-yl)methyl]-3-hydroxynaphthalene-2-carboxylic acid,1-methyl-2-[(E)-2-thiophen-2-ylethenyl]-5,6-dihydro-4H-pyrimidine, 4-[(3-carboxy-2-hydroxynaphthalen-1-yl)methyl]-3-hydroxynaphthalene-2-carboxylic acid; 1-methyl-2-[(E)-2-thiophen-2-ylethenyl]-5,6-dihydro-4H-pyrimidine, 4-[(3-carboxy-2-oxidanyl-naphthalen-1-yl)methyl]-3-oxidanyl-naphthalene-2-carboxylic acid; 1-methyl-2-[(E)-2-thiophen-2-ylethenyl]-5,6-dihydro-4H-pyrimidine, Pyrimidine, 1,4,5,6-tetrahydro-1-methyl-2-[2-(-2-thienyl)ethenyl-, (E)-, with 4,4'-methylenebis[3-hydroxy-2-naphthalenecarboxylic acid (1:1)